Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Tom D who wrote (388)	12/10/1997 11:03:00 PM
From: chirodoc	Respond to of 887

Spoke to investor relations today. ........maybe it was stupid but it needed to have a few of my intuitions confirmed. .......yes they are very bullish about the odac meeting. no, this is not equivalent ot fda approval but they said that a yes vote was an ALMOST certain sign of later approval. ......she reiterated that approval at this meeting would signify approval of their unqiue delivery system and more new drugs will follow after morphine and anti-biotics. .....she was very upbeat in tone when she said that they were going to confine their studys to already approved drugs--they are not looking for "new molecules." ......this is what i wanted to hear. although it has been said before i wanted to share it with everyone. especially her tone--seemed very positive. that being said--if meeting decision is negative we will all feel like those guys in toms st louis shelter.